Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()

• Cutaneous metastases are rare and clinically challenging to manage. When present, they often represent end-stage disease. • Treatments for cutaneous metastases are limited, and primarily palliative in nature.

Detalles Bibliográficos
Autores principales: Craig, Christine D., Iglesias, David A., Watkins, Jack, Coleman, Robert L., Kilgore, Larry, Ramirez, Pedro T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862230/
https://www.ncbi.nlm.nih.gov/pubmed/24371701
http://dx.doi.org/10.1016/j.gynor.2013.05.005
_version_ 1782295723507712000
author Craig, Christine D.
Iglesias, David A.
Watkins, Jack
Coleman, Robert L.
Kilgore, Larry
Ramirez, Pedro T.
author_facet Craig, Christine D.
Iglesias, David A.
Watkins, Jack
Coleman, Robert L.
Kilgore, Larry
Ramirez, Pedro T.
author_sort Craig, Christine D.
collection PubMed
description • Cutaneous metastases are rare and clinically challenging to manage. When present, they often represent end-stage disease. • Treatments for cutaneous metastases are limited, and primarily palliative in nature.
format Online
Article
Text
id pubmed-3862230
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-38622302013-12-26 Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()() Craig, Christine D. Iglesias, David A. Watkins, Jack Coleman, Robert L. Kilgore, Larry Ramirez, Pedro T. Gynecol Oncol Case Rep Case Report • Cutaneous metastases are rare and clinically challenging to manage. When present, they often represent end-stage disease. • Treatments for cutaneous metastases are limited, and primarily palliative in nature. Elsevier 2013-05-19 /pmc/articles/PMC3862230/ /pubmed/24371701 http://dx.doi.org/10.1016/j.gynor.2013.05.005 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Craig, Christine D.
Iglesias, David A.
Watkins, Jack
Coleman, Robert L.
Kilgore, Larry
Ramirez, Pedro T.
Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
title Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
title_full Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
title_fullStr Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
title_full_unstemmed Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
title_short Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
title_sort extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862230/
https://www.ncbi.nlm.nih.gov/pubmed/24371701
http://dx.doi.org/10.1016/j.gynor.2013.05.005
work_keys_str_mv AT craigchristined extensivecutaneousmetastasesofovariancancerafterprolongedresponsetoliposomaldoxorubicin
AT iglesiasdavida extensivecutaneousmetastasesofovariancancerafterprolongedresponsetoliposomaldoxorubicin
AT watkinsjack extensivecutaneousmetastasesofovariancancerafterprolongedresponsetoliposomaldoxorubicin
AT colemanrobertl extensivecutaneousmetastasesofovariancancerafterprolongedresponsetoliposomaldoxorubicin
AT kilgorelarry extensivecutaneousmetastasesofovariancancerafterprolongedresponsetoliposomaldoxorubicin
AT ramirezpedrot extensivecutaneousmetastasesofovariancancerafterprolongedresponsetoliposomaldoxorubicin

Ejemplares similares